Yang, Y., Guo, Q., Chen, X., Zhang, J., Guo, H., Qian, W., . . . Wang, H. (2016). Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy. MAbs.
Stile di citazione ChicagoYang, Yun, et al. "Preclinical Studies of a Pro-antibody-drug Conjugate Designed to Selectively Target EGFR-overexpressing Tumors With Improved Therapeutic Efficacy." MAbs 2016.
Citazione MLAYang, Yun, et al. "Preclinical Studies of a Pro-antibody-drug Conjugate Designed to Selectively Target EGFR-overexpressing Tumors With Improved Therapeutic Efficacy." MAbs 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.